- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 79.05M sh |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $236.07M |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $239.15M |
| Short Term Debt | Q1 2025 · Mar 29, 2025 | $98.02M |
| Short Term Debt | Q1 2025 · Dec 28, 2024 | $98.02M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $468.21M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $468.27M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $254.12M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $249.83M |
| Total Assets | Q1 2025 · Mar 29, 2025 | $2.01B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $2.01B |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $73.95M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2024 | $150.05M |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 78.83M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $2.72M |
| Capex | Q1 2025 · Mar 30, 2024 | $20.01M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $23.99M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $841.32M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $829.42M |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.15 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.15 |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $240.13M |
| Net Income | Q1 2025 · Mar 30, 2024 | $11.69M |
| Operating Income restated | Q1 2025 · Mar 30, 2024 | $23.44M |
| Revenue restated | Q1 2025 · Mar 30, 2024 | $482.79M |